In a landmark decision that will reshape how we approach obesity treatment worldwide, the World Health Organization1 has released its first-ever clinical guidelines recommending GLP-1 therapies for adults living with obesity. This isn’t merely another drug approval or incremental policy update; it represents a transformation in how the world’s leading health authority understands and addresses a condition affecting over 1 billion people globally.
Similar Posts
Video: What Would Happen If Prior Authorization Went Away?
[embedded content] Prior authorization has been a bone of contention between payers and providers for some…
Why Human Connection Can’t Be Replaced in Counseling
In today’s digital world, virtual communication has become more common than ever. Online therapy offers convenience…
How Kaiser Permanente Consolidated 12 EHRs into 2
Earlier this year, Kaiser Permanente completed one of the largest IT projects in the health system’s…
How Many Monsters Can Kill You?
Share this post Monsters fan. You can feel that your preferred energy drink is the only…
These 10 Best Duvet Inserts Will Help You Drift Off to Dreamland
With the Well+Good SHOP, our editors put their years of know-how to work in order to…
Beauty Refresh Awards 2024: Skin Care Products For Longevity
Review from editor Alexandra Engler “What an eye serum! I’ve been through two bottles already and…
